These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A new facet of ADP-ribosylation reactions: SIRTs and PARPs interplay. Faraone-Mennella MR Front Biosci (Landmark Ed); 2015 Jan; 20(3):458-73. PubMed ID: 25553461 [TBL] [Abstract][Full Text] [Related]
6. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Zhang J Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452 [TBL] [Abstract][Full Text] [Related]
7. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645 [TBL] [Abstract][Full Text] [Related]
8. Natural inhibitors of poly(ADP-ribose) polymerase-1. Banasik M; Stedeford T; Strosznajder RP Mol Neurobiol; 2012 Aug; 46(1):55-63. PubMed ID: 22476980 [TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribosyl)ation and stroke. Chiarugi A Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330 [TBL] [Abstract][Full Text] [Related]
10. The PARP Way to Epigenetic Changes. Ummarino S; Hausman C; Di Ruscio A Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804735 [TBL] [Abstract][Full Text] [Related]
11. Sirtuins: Promising Therapeutic Targets to Treat Ischemic Stroke. Liu Y; Wang L; Yang G; Chi X; Liang X; Zhang Y Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627275 [TBL] [Abstract][Full Text] [Related]
12. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs. Carter-O'Connell I; Cohen MS Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237 [TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy. Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836 [TBL] [Abstract][Full Text] [Related]
14. The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture. Kim YH; Koh JY Exp Neurol; 2002 Oct; 177(2):407-18. PubMed ID: 12429187 [TBL] [Abstract][Full Text] [Related]
15. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro. Lin KY; Huang D; Kraus WL Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863 [TBL] [Abstract][Full Text] [Related]
16. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Cantó C; Sauve AA; Bai P Mol Aspects Med; 2013 Dec; 34(6):1168-201. PubMed ID: 23357756 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer. Navas LE; Carnero A Cells; 2022 Aug; 11(17):. PubMed ID: 36078035 [TBL] [Abstract][Full Text] [Related]
18. Implications of NAD Kang BE; Choi JY; Stein S; Ryu D Eur J Clin Invest; 2020 Oct; 50(10):e13334. PubMed ID: 32594513 [TBL] [Abstract][Full Text] [Related]
19. Interplay between mitochondrial metabolism and oxidative stress in ischemic stroke: An epigenetic connection. Narne P; Pandey V; Phanithi PB Mol Cell Neurosci; 2017 Jul; 82():176-194. PubMed ID: 28552342 [TBL] [Abstract][Full Text] [Related]
20. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]